RDUS Chart
- 52-Week Range: $5.53 - $22.31
- Market Capitalization: $481.48M
- Short Percentage: 0%
- Target Price: $9.60
- Shares Outstanding: 47.62M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
RDUS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Gurnet Point Capital and Patient Square Capital Complete Their Acquisition of Radius Health, Inc.GlobeNewsWire | August 15th
- Velan-Repertoire to Withdraw Director Nominations Due to Pending Sale of Radius HealthBusiness Wire | July 11th
- SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Radius Health, Inc. MergerNewsfile Corp | June 24th
Company Info
Website: https://radiuspharm.com
Address: 22 Boston Wharf Road, Boston, MA, United States, 02210
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 293
Address: 22 Boston Wharf Road, Boston, MA, United States, 02210
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 293
$RDUS might get a sell off today
$RDUS I love you!
$RDUS the best advice has been no stop losses. Would have cost a fortune!!!
$RDUS ready to explode
$RDUS I blocked some bears and I liked it!
$RDUS the FOMO will be epic
$RDUS back to business
$RDUS I REALLY THINK WE FINALLY HAVE OUR FIRESALE?? !!
$RDUS this is my only green stonk!
I really like this stonk.
$RDUS my lotto for earnings